Objectives: This study examined the association between loneliness and alcohol consumption among Korean adults and explored the differences across sociodemographic subgroups, including sex, age, income, occupation, and marital status. Methods: Data were obtained from the 2021 National Mental Health Survey of Korea, including 5491 adults aged 18 years or older. Loneliness was measured using the Loneliness and Social Isolation Measure-6 (LSIS-6). Alcohol consumption was categorized as abstinence, moderate drinking, or high-risk drinking. Depressive symptoms were classified according to the KoreanComposite International Diagnostic Interview (K-CIDI) criteria. The group differences were assessed using analysis of variance (ANOVA) and chi-square tests. Complex-sample multinomial logistic regression was performed to examine the associations between loneliness and alcohol consumption while adjusting for age, gender, income, occupation, and marital status. Results: Sociodemographic characteristics significantly differed across alcohol-use groups. After adjusting for the covariates and depressive symptoms, loneliness remained positively associated with high-risk drinking. Age-stratified analyses suggested that this association was observed only among adults aged 60 years and older. Moderate drinking was not significantly associated with loneliness in all age groups. Conclusion Loneliness was independently associated with high-risk drinking in Korean adults, particularly in older adults. These findings highlight the importance of incorporating social isolation and loneliness into alcohol-related screening and prevention strategies, especially for aging populations.

This paper reports two clinical cases of men in their twenties who presented with compulsive sexual behaviors characterized by excessive pornography use and illegal voyeuristic activities. Although both individuals maintained otherwise adequate social and academic functioning, they experienced psychological distress and faced legal consequences stemming from their inability to control their sexual impulses. Pharmacological treatment with naltrexone and fluoxetine was associated with a reduction in their compulsive urges. Compulsive sexual behavior disorder (CSBD) has not yet been formally included in the Diagnostic and Statistical Manual of Mental Disorders (DSM), and its status as a potential behavioral addiction remains under debate. Voyeuristic behavior is classified within paraphilic disorders, which are considered diagnostically separate from CSBD despite substantial clinical overlap. These cases contribute to the ongoing discussions regarding the conceptualization of CSBD and highlight the importance of recognizing and expanding the therapeutic approaches for individuals struggling with impaired sexual impulse control.

Objectives: This study evaluated the educational effectiveness of the Loving Life TokTok 65+, a suicide prevention gatekeeper education program for the elderly developed by the Jeju Special Self-Governing Province Mental Health Welfare Center. Methods: Community-dwelling adults aged ≥65 years (n=125) were assigned randomly to an intervention group (n=61) or a control group (n=64). The intervention group received the Loving Life TokTok 65+ program, while the control group received no education during the study period. The outcomes were assessed immediately before and after the intervention using validated self-report measures of gatekeeper behavior, preparedness to help, suicide prevention literacy, and attitudes toward suicide. Results: Post-intervention, the intervention group showed significant improvement in overall gatekeeper behavior (all p<0.001), particularly in readiness and self-efficacy, compared with the baseline, whereas the control group showed no significant change. Conclusion The Loving Life TokTok 65+ program effectively enhanced suicide-prevention–related behavioral competencies among the elderly.

Electroconvulsive therapy (ECT) is performed under general anesthesia, and the choice of anesthetic induction agents critically influences multiple aspects of the treatment, including the seizure quality, cardiovascular stability, and post-procedural recovery. Developing anesthetic strategies that reliably achieve loss of consciousness while preserving adequate seizure expression has been a central challenge in ECT practice because most commonly used induction agents possess anticonvulsant properties. Dexmedetomidine (DEX), recently introduced primarily for sedation in intensive care and various procedural settings, is a selective α2-adrenergic receptor agonist that has minimal impacts on the seizure threshold and seizure duration while providing a complex profile of sedation, analgesia, anxiolysis, and sympatholysis. These properties help reduce the acute increases in blood pressure and heart rate induced by electrical stimulation, and DEX also offers advantages for airway management because it induces virtually no respiratory depression.Importantly, DEX has also been consistently reported to reduce pre-procedural anxiety and postictal agitation or aggression, suggesting that it may allow more stable management throughout the entire ECT course compared with conventional anesthetic agents. This review examines the pharmacological characteristics and clinical implications of DEX in anesthetic induction for ECT and discusses its potential roles in future clinical practice.

This article re-examines Freud’s unpublished draft, A Phylogenetic Fantasy, as an attempt to locate anxiety and neurosis at the level of human phylogeny and offers a reinterpretation within contemporary evolutionary psychiatry. Primary sources, including A Phylogenetic Fantasy and related metapsychological papers, were critically reviewed together with key secondary literature on Freud’s evolutionary thinking. Freud’s analysis of the six factors of the transference neuroses, his Ice Age hypothesis on sexuality and reproductive strategy, and the narrative of the primal horde and primal father were reconstructed and compared with recent work on epigenetics, the Baldwin effect, gene culture coevolution, and the social brain. Freud’s phylogenetic model, although grounded in Lamarckism and speculative anthropology, anticipates several core themes in evolutionary psychiatry by linking transference and narcissistic neuroses to species-level dispositions, developmental stages, and age of onset. Concepts such as phylogenetic memory and disposition are reconceptualized as multilayered vulnerabilities arising from the interactions among genetic predispositions, epigenetic tuning of stress systems, developmental trajectories, and the cultural transmission of narratives regarding danger, guilt, authority, and kinship. A Phylogenetic Fantasy is presented not as a testable etiological theory but as a thought experiment that foreshadows the central questions of evolutionary psychiatry regarding the vulnerabilities of the human mind. This review suggests that anxiety disorders, obsessive–compulsive and related disorders, schizophrenia spectrum disorders, and mood disorders can be reconsidered within an evolutionary vulnerability stress framework that considers the developmental timing and the longterm ecological and social histories.

Suicide prevention remains one of the most complex and important tasks in psychiatric practice.Lithium and clozapine have long been considered potential anti-suicidal agents, but the strength and scope of their evidence are largely diagnosis-specific. In clinical settings, however, these drugs are occasionally used in broader contexts, including cases where suicidal ideation itself becomes the primary indication. This raises the need to critically examine how pharmacologic interventions should be applied within appropriate diagnostic and therapeutic frameworks. This review synthesizes existing evidence on lithium and clozapine and discusses their roles within the broader landscape of suicide prevention. Suicide is not a unitary symptom but a multifactorial outcome shaped by biological, psychological, and social determinants. Accordingly, pharmacologic treatment should be understood as one component of a multidimensional strategy that integrates psychotherapy, crisis intervention, and social support systems. From an interpretive standpoint, this review highlights the importance of aligning medication use with established evidence while maintaining clinical flexibility and individualized care. The goal was not to depreciate the therapeutic value of lithium or clozapine but to contextualize their use within a rational, diagnosis-informed, and ethically grounded framework. This paper contributes to a more nuanced and evidence-based model of suicide prevention in psychiatric practice by reinforcing such an integrative approach.

Objectives: This study examined the research trends in the field of the five addictions, examining the correlations and co-occurrence among addiction studies. Methods: Bibliographic information from papers was used to examine the correlations and cooccurrence between different fields of addiction. The analysis covered the entire period and specific time frames. Correlation analysis was conducted using cosine similarity, while co-occurrence analysis was performed using text network analysis. Results: An analysis of the correlations and co-occurrence among the five addictions revealed the following. First, since 2000, studies on internet and smartphone addiction have become more active, leading to a significant increase in research connections between the different types of addiction. Second, there is a high correlation between alcohol addiction and internet addiction, with shared research topics being actively explored. Finally, the most commonly addressed topic across studies on the five addictions is adolescent addiction. Conclusion The significance of this study lies in its contribution to understanding the trends in addiction-related research and the insights into the treatment of cross-addiction.

Bipolar disorder is the main approved indication of mood stabilizers. In clinical practice, however, they are commonly used for 1) patients showing aggressive behavior regardless of the diagnosis and 2) schizophrenia patients. A literature review was performed to find evidence supporting this clinical “common sense.” The authors found no sufficient evidence supporting the efficacy of mood stabilizers either for aggressive behavior or for schizophrenia. The authors suggest that off-label use of mood stabilizers should be based on judicious clinical judgment, based on the understanding “what particular treatment for this patient does the behavior warrant at this time?”

Objectives: This study examined the research trends in the field of the five addictions, examining the correlations and co-occurrence among addiction studies. Methods: Bibliographic information from papers was used to examine the correlations and cooccurrence between different fields of addiction. The analysis covered the entire period and specific time frames. Correlation analysis was conducted using cosine similarity, while co-occurrence analysis was performed using text network analysis. Results: An analysis of the correlations and co-occurrence among the five addictions revealed the following. First, since 2000, studies on internet and smartphone addiction have become more active, leading to a significant increase in research connections between the different types of addiction. Second, there is a high correlation between alcohol addiction and internet addiction, with shared research topics being actively explored. Finally, the most commonly addressed topic across studies on the five addictions is adolescent addiction. Conclusion The significance of this study lies in its contribution to understanding the trends in addiction-related research and the insights into the treatment of cross-addiction.

Bipolar disorder is the main approved indication of mood stabilizers. In clinical practice, however, they are commonly used for 1) patients showing aggressive behavior regardless of the diagnosis and 2) schizophrenia patients. A literature review was performed to find evidence supporting this clinical “common sense.” The authors found no sufficient evidence supporting the efficacy of mood stabilizers either for aggressive behavior or for schizophrenia. The authors suggest that off-label use of mood stabilizers should be based on judicious clinical judgment, based on the understanding “what particular treatment for this patient does the behavior warrant at this time?”